如果按照控制结核战略的建议在整个卫生系统中紧急采取结核病控制措施，就可制止耐多药结核病和广泛耐药结核病的全球威胁。
The global threat of MDR-TB and XDR-TB (M/XDR-TB) can be halted if TB control measures are urgently put in place across the whole health system as recommended under the Stop TB Strategy.
回到前抗生素时代的威胁是真实的，而耐多药和广泛耐药结核病的增多则是最生动的实例。
The threat of returning to a pre-antibiotic era is genuine and probably most vividly illustrated by the rise of multidrug-resistant and extensively drug-resistant tuberculosis.
去年世卫组织抗结核耐药报告说明了在一般人群中结核病耐多药情况已达到前所未有的最高水平。
Last year, the WHO report on anti-TB drug resistance documented the highest levels of multi-drug resistance ever recorded in a general population.
耐多药结核病是耐药结核病的一种特殊形式，由于某一杆菌至少对异烟肼和利福平这两个最强有力的抗结核药品产生耐药而造成。
MDR-TB is a specific form of drug-resistant TB due to a bacillus resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.
自2009年以来，受到耐药结核病影响最重的23个国家已经将用于耐多药结核病的预算几近翻番。
Since 2009, the 23 countries most heavily affected by TB drug resistance have nearly doubled their budgets for MDR-TB.
现在已有50多个国家报告出现广泛耐药结核病[2]。这是耐多药结核的一个分类，耐药性极高，结果也显著地更严重。
XDR-TB 2, a subset of MDR-TB of highly drug-resistant strains that have significantly worse outcomes, has now been reported in more than 50 countries.
现在已有50多个国家报告出现广泛耐药结核病[2]。 这是耐多药结核的一个分类，耐药性极高，结果也显著地更严重。
XDR-TB2, a subset of MDR-TB of highly drug-resistant strains that have significantly worse outcomes, has now been reported in more than 50 countries.
以前的报告中发现，艾滋病毒携带者同时感染耐多药结核病和广泛耐药结核病的病例中死亡率很高。
Previous reports found high levels of mortality among people living with HIV and infected with MDR-TB and XDR-TB.
在许多国家，艾滋病毒加快了结核病流行，同时多药耐药性也日益成为一大威胁。
HIV is fuelling TB epidemics in many countries and multi-drug resistance is a growing threat.
耐多药结核病是由对多数有效抗结核病药物（异烟肼和利福平）都具有耐药性的细菌引起的。
MDR-TB is caused by bacteria that are resistant to the most effective anti-TB drugs (isoniazid and rifampicin).
预防和控制耐多药结核病和广泛耐药结核病。
Prevention and control of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.
使用一个疗程标准结核病药物的成本约为20美元，而耐多药结核病药物的成本可以高达5000美元，广泛耐药结核病的治疗费用则更加昂贵。
While a course of standard TB drugs cost approximately US$ 20, MDR-TB drugs can cost up to US$ 5 000, and XDR-TB treatment is far more expensive.
确保制定一个耐多药/广泛耐药结核病综合管理与治疗框架；
to ensure development of a comprehensive M/XDR-TB management and care framework;
开发抗击耐多药/广泛耐药结核病所需要的新工具。
虽然药物敏感结核病可以在6个月内治愈，耐药类型的结核病（如：耐多药结核病）需要进行长达两年的全面化疗（使用具有更多副作用的药品）。
While drug-susceptible TB can be cured within six months, forms of drug-resistant TB (such as MDR-TB) require extensive chemotherapy (with drugs which have more side effects) for up to two years.
世卫组织/国际防痨和肺部疾病联盟的全球耐药监测项目已经在东欧、拉丁美洲、非洲和亚洲发现了耐多药结核病（占新发结核病例的比率>4％）。
The WHO/IUATLD Global Project on Drug Resistance Surveillance has found MDR-TB (prevalence > 4% among new TB cases) in Eastern Europe, Latin America, Africa, and Asia.
结核病的耐药性分成单耐药、多耐药、耐多药、严重耐多药这几个层次。
TB drug resistance is divided into single-drug resistance, multidrug resistance, MDR, MDR-serious levels of these.
目的：了解当前结核病对一线及二线抗结核药物的耐药性及耐多药情况，为结核病防治提供依据。
Objective: To investigate the resistance status of Bacillus tuberculosis to anti?tuberculosis drugs of fist and second ranks in use, and so as to provide basic data for tuberculosis (TB)prevention .
目的：了解当前结核病对一线及二线抗结核药物的耐药性及耐多药情况，为结核病防治提供依据。
Objective: To investigate the resistance status of Bacillus tuberculosis to anti?tuberculosis drugs of fist and second ranks in use, and so as to provide basic data for tuberculosis (TB)prevention .
应用推荐